register

News & Trends - Pharmaceuticals

Organon expands commitment to women’s health, gender equity and climate change through local partnerships

Health Industry Hub | November 7, 2022 |

Pharma News: Organon has signed partnership agreements with National Youth Science Forum (NYSF) and Sister2sister in Australia. These partnerships strengthen Organon’s purpose to support women and girls in achieving their full potential by addressing gender-related disparities in wellbeing and STEM related education, and building a more sustainable future for women, families, economies and society.

“At Organon, we want to help women and girls achieve their promise by leading healthier, more empowered lives. We are working toward this purpose using multiple approaches, including innovating in women’s health, expanding access to needed medicines and other products, and advancing equity inside and outside the company,” said Nirelle Tolstoshev, Managing Director, Organon ANZ.

“Organon recently launched its first Environment, Sustainability and Governance (ESG) Report, and our partnerships with both National Youth Science Forum (supporting the Year 12 STEM Program) and Sister2sister (supporting No Limits 4Girls Program), align to our commitment to be of service to communities to support healthy lifestyles, advance the health of women, and advance equity across a number of metrics, including education and opportunity for participation.

Budget debrief and next moves for HTA Review: Medicines Australia CEO, HTA Committee member

“Our commitment goes beyond a financial contribution. Organon’s employee volunteer policy encourages our employees to dedicate 40 regularly scheduled work hours per calendar year toward volunteer activities. “We believe that cultivating an environment of service to the communities in which we live and work serves our employees by enriching the quality of their lives and by providing opportunities for service experiences; builds trust with our partners and enhances our employee skills, talents and experiences.

“We look forward to the contribution Organon will bring to our programs so we can continue to provide immersive and life-changing experiences, ensuring we connect young people with the broadest possible range of STEM careers and how to get there,” said Dr Melanie Bagg, CEO of NYSF.

“Often school students have limited awareness of what careers they can enter to help others and make a tangible difference in their communities. Real-life industry insight from organisations like Organon helps our students meet real STEM professionals and explore a broad range of jobs in healthcare, pharmaceutical and the medical sector.”

A healthcare sector gap in ESG reporting should be a wake-up call

“We are proud to be in partnership with Organon to deliver our No Limits 4 Girls Program (NL4G). We want young girls to feel empowered, respected, confident and equipped to make the most of opportunities that they have ahead of them. Furthermore, giving students the ability to listen to each other’s’ experiences will allow them to feel safe and connect on a deeper level. Sister2sister has had a lasting impact on many lives, and we hope NL4G has the same effect throughout these young girls’ schooling life,” commented Marnee May, CEO of Sister2sister Foundation.

“We are incredibly proud to partner with both National Youth Science Forum and Sister2sister to support the work they do in improving the health and equity for women and girls,” Tolstoshev concluded.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Biotechnology

Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research

Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research

Health Industry Hub | July 26, 2024 |

Biotech News: Australian biotechnology company, Cartherics, developing immune cell therapies for the treatment of cancer, has entered into a Technology […]

More


News & Trends - MedTech & Diagnostics

NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey

NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey

Health Industry Hub | July 26, 2024 |

In a heart-warming event that united patients, their loved ones, representatives from patient organisations and employees, Edwards Lifesciences hosted its […]

More


Human Resources

'To be an inclusive society, we need an embedded national strategy to combat systemic racism', says Commissioner Sivaraman

‘To be an inclusive society, we need an embedded national strategy to combat systemic racism’, says Commissioner Sivaraman

Health Industry Hub | July 26, 2024 |

Race Discrimination Commissioner Giridharan Sivaraman has welcomed the release of the Multicultural Framework Review by the Federal Government, calling it […]

More


News & Trends - Pharmaceuticals

New shingles vaccine is linked with lower risk of dementia

Shingles vaccine lowers risk of dementia

Health Industry Hub | July 26, 2024 |

Pharma News: A recombinant shingles vaccine which was added to Australia’s National Immunisation Program (NIP) in November last year, is […]

More


This content is copyright protected. Please subscribe to gain access.